Journal Logo

September 2019 - Volume 270 - Issue 3
pp: 391-572

Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer

Macedo, Francis I.; Ryon, Emily; Maithel, Shishir K.; More

Annals of Surgery. 270(3):400-413, September 2019.

A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients

Zaidi, Mohammad Y.; Lopez-Aguiar, Alexandra G.; Switchenko, Jeffrey M.; More

Annals of Surgery. 270(3):422-433, September 2019.

Description and Impact of a Comprehensive Multispecialty Multidisciplinary Intervention to Decrease Opioid Prescribing in Surgery

Kaafarani, Haytham M. A.; Eid, Ahmed I.; Antonelli, Donna M.; More

Annals of Surgery. 270(3):452-462, September 2019.

Long-term Patient-reported Outcomes Following Postmastectomy Breast Reconstruction: An 8-year Examination of 3268 Patients

Nelson, Jonas A.; Allen, Robert J. Jr; Polanco, Thais; More

Annals of Surgery. 270(3):473-483, September 2019.

Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative

Newman, Lisa A.; Jenkins, Brittany; Chen, Yalei; More

Annals of Surgery. 270(3):484-492, September 2019.